Sankei ChemicalSANKEI CHEMICAL CO.,LTD.4995福岡証券取引所化学FY ending Nov 2025, consolidated, J-GAAP

Sankei Chemical revenue and profit

Out of every ¥100 of sales, about ¥3 is left as operating profit. Revenue changed +6.5% from the prior year, operating profit +298.3%.

Five-year trend

Revenue¥6.44B
FY ending Nov 2021: ¥7.03B¥7.03BFY ending Nov 2022: ¥7.24B¥7.24BFY ending Nov 2023: ¥6B¥6BFY ending Nov 2024: ¥6.05B¥6.05BFY ending Nov 2025: ¥6.44B¥6.44BFY21FY22FY23FY24FY25
Operating income¥180.7M
FY ending Nov 2021: ¥392.3M¥392.3MFY ending Nov 2022: ¥233.2M¥233.2MFY ending Nov 2023: -¥11.6M-¥11.6MFY ending Nov 2024: ¥45.4M¥45.4MFY ending Nov 2025: ¥180.7M¥180.7MFY21FY22FY23FY24FY25
Operating margin2.8%
FY ending Nov 2021: 5.6%5.6%FY ending Nov 2022: 3.2%3.2%FY ending Nov 2023: -0.2%-0.2%FY ending Nov 2024: 0.7%0.7%FY ending Nov 2025: 2.8%2.8%FY21FY22FY23FY24FY25

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin2.8%
Asset turnover0.82×
ROA2.3%
ROA2.3%
Financial leverage2.60×
ROE6.0%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin2.8%
2021: 4.5%4.5%2022: 2.9%2.9%2023: 0.6%0.6%2024: 2.2%2.2%2025: 2.8%2.8%2122232425
Asset turnover0.82×
2021: 0.92×0.92×2022: 0.92×0.92×2023: 0.77×0.77×2024: 0.79×0.79×2025: 0.82×0.82×2122232425
ROA2.3%
2021: 4.1%4.1%2022: 2.7%2.7%2023: 0.5%0.5%2024: 1.7%1.7%2025: 2.3%2.3%2122232425
Financial leverage2.60×
2021: 2.83×2.83×2022: 2.81×2.81×2023: 2.71×2.71×2024: 2.63×2.63×2025: 2.60×2.60×2122232425
ROE6.0%
2021: 11.6%11.6%2022: 7.6%7.6%2023: 1.3%1.3%2024: 4.6%4.6%2025: 6.0%6.0%2122232425
PeriodNet marginAsset turnoverROAFinancial leverageROE
20214.5%0.92×4.1%2.83×11.6%
20222.9%0.92×2.7%2.81×7.6%
20230.6%0.77×0.5%2.71×1.3%
20242.2%0.79×1.7%2.63×4.6%
20252.8%0.82×2.3%2.60×6.0%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue18.8%
2020: 10.7%10.7%2021: 10.4%10.4%2022: 13.3%13.3%2023: 18.9%18.9%2024: 18.3%18.3%2025: 18.8%18.8%202122232425
PPE ÷ total assets15.3%
2020: 10.1%10.1%2021: 9.6%9.6%2022: 11.9%11.9%2023: 15.0%15.0%2024: 14.3%14.3%2025: 15.3%15.3%202122232425

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥282M
2020: ¥180M¥180M2021: ¥183M¥183M2022: ¥218M¥218M2023: ¥233M¥233M2024: ¥224M¥224M2025: ¥282M¥282M202122232425
R&D / revenue4.4%
2020: 2.7%2.7%2021: 2.6%2.6%2022: 3.0%3.0%2023: 3.9%3.9%2024: 3.7%3.7%2025: 4.4%4.4%202122232425
Receivable days65d
2020: 75d75d2021: 73d73d2022: 72d72d2023: 65d65d2024: 78d78d2025: 65d65d202122232425
Payable days—
2020: 74d74d2021: 84d84d2022: 75d75d2023: 61d61d2024: 68d68d202122232425

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Nov 2021FY ending Nov 2022FY ending Nov 2023FY ending Nov 2024FY ending Nov 2025
Revenue7,0327,2435,9986,0526,444
Cost of revenue5,2125,6724,6664,6844,840
Gross profit1,8201,5701,3331,3691,605
SG&A1,4281,3371,3441,3231,424
Operating income392233-1245181
Pretax income44530054219215
Income tax12081105230
Net income attributable to owners31421237133181
Operating margin5.6%3.2%-0.2%0.7%2.8%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 24%
Receivables 15%
Property, plant and equipment 15%
0%
Investment securities 14%
Other assets 32%

Funding

Other liabilities 57%
Equity 43%
0%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Nov 2021FY ending Nov 2022FY ending Nov 2023FY ending Nov 2024FY ending Nov 2025
Cash and equivalents¥2.16B¥2.08B¥1.64B¥1.9B¥1.92B
Total assets¥7.64B¥8.07B¥7.54B¥7.72B¥7.92B
Net assets¥3B¥3.21B¥3.22B¥3.24B¥3.41B
Share capital¥664.5M¥664.5M¥664.5M¥664.5M¥664.5M
Trade receivables¥1.4B¥1.42B¥1.06B¥1.29B¥1.14B
Property, plant and equipment¥733.4M¥961.2M¥1.13B¥1.11B¥1.21B
Intangible assets excluding goodwill¥4M¥1.9M¥660K¥253K¥5.2M
Investment securities¥951.6M¥1.01B¥1.05B¥1.01B¥1.13B
Current assets¥5.78B¥5.9B¥5.18B¥5.38B¥5.36B
Current liabilities¥2.72B¥2.73B¥2.12B¥2.26B¥2.43B
Trade payables¥1.2B¥1.16B¥779.2M¥877.4M—
Long-term borrowings¥1.23B¥1.44B¥1.5B¥1.48B¥1.34B
Total liabilities¥4.64B¥4.86B¥4.32B¥4.48B¥4.5B
Non-controlling interests¥111.7M¥116.8M¥121.2M¥152.4M¥150.7M
Equity attributable to owners of parent¥2.7B¥2.89B¥2.87B¥2.93B¥3.09B
Retained earnings¥1.81B¥1.99B¥2B¥2.11B¥2.27B
Treasury stock-¥68M-¥68M-¥89.1M-¥141.7M-¥142M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第101期(2024/12/01-2025/11/30)

    ID S100XNCR2026-02-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第100期(2023/12/01-2024/11/30)

    ID S100VB1V2025-02-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第99期(2022/12/01-2023/11/30)

    ID S100SYCM2024-02-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第98期(2021/12/01-2022/11/30)

    ID S100QAIN2023-02-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第97期(令和2年12月1日-令和3年11月30日)

    ID S100NK652022-02-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第96期(令和1年12月1日-令和2年11月30日)

    ID S100KVKN2021-02-26Open

Extracted from XBRL: 52 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.